학술논문
MPN-354 Characteristics of Patients With Myelofibrosis Taking Ruxolitinib for 3 or More Years
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S334-S334
Subject
Language
ISSN
2152-2650